• OTELIXIZUMAB chembl:CHEMBL1743053

    Alternate Names:

    CHAGLY CD3
    CHAGLYCD
    OTELIXIZUMAB
    TRX-4
    CHAGLYCD3
    CHAGLYCD-3

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antidiabetic,antiinflammatory agent,DMARD
    (1 More Sources)

    Publications:

  • Interaction Score: 6.38

    Interaction Types & Directionality:
    antibody (inhibitory)

    Interaction Info:
    Direct Interaction? True
    Endogenous Drug? False
    Specific Action of the Ligand Binding

  • Interaction Score: 3.04

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name otelixizumab, TRX4, GSK2136525
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 1.64

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name otelixizumab, TRX4, GSK2136525
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial